Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Six Months Adalimumab Treatment on Sick Leaves and Retirement in Patients With Rheumatoid Arthritis Who Are at a Risk of Losing Their Ability to Work

NCT01405326 is registered in ClinicalTrials.gov with The Rheumatological Center of Helsinki as lead sponsor.

NCT NCT01405326
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01405326 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Six Months Adalimumab Treatment on Sick Leaves and Retirement in Patients With Rheumatoid Arthritis Who Are at a Risk of Losing Their Ability to Work
Lead sponsor
The Rheumatological Center of Helsinki
Phase
Phase 4
Overall status
Unknown status
Start date
May 31, 2011
Completion date
March 31, 2013
Enrollment
160 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis